Skip menus, go to main page content

To Our Shareholders
and Investors

Top
To Our Shareholders and Investors

IR News

July 03, 2025

Management & Finance

Nippon Shinyaku Selected as a Constituent of the SOMPO Sustainability Index
July 01, 2025

R & D

Announcement of Strategic Alliance with Boston Children's Hospital
May 14, 2025

R & D

RGX-121 (clemidsogene lanparvovec) : The U.S. FDA has accepted the Biologics License Application by REGENXBIO for Mucopolysaccharidosis II Disease
May 08, 2025

Management & Finance

Outline of Consolidated Financial Results for the Year Ended March 31, 2025

Upcoming Events

May 08, 2025
IR Meeting (Q4/FY2024) PDF1 MB
May 08, 2025
FY2024 Annual results announcement PDF1.9 MB
February 18, 2025
R&D Meeting PDF1.7 MB
February 07, 2025
Conference Call(Q3/FY2024) PDF921 KB
February 07, 2025
FY2024 3rd Qtr results announcement PDF780 KB

Financial/Capital Strategy

Management Policy and Plan

Business/Financial Information

IR Library

Sustainability Management

Stock and Shareholder Information

To Our Individual Investors

IR e-mail

Subscribe (only 1 minute required) to receive the latest news by e-mail.

Most Viewed Pages

June 1-30, 2025

All Japanese Listed Companies' Website Ranking

Gomez
IR Site Ranking Silver 2024

Daiwa Investor Relations Co.Ltd. 2024 Internet IR Award

Related Link

Nippon Shinyaku’s DNA

Research & Development

Top
To Our Shareholders and Investors